Open access
Aug 2026
Longitudinal changes in left atrial function during chronic ibrutinib therapy: a prospective observational study
Background Ibrutinib is effective for B-cell malignancies but is associated with cardiovascular adverse events, including atrial fibrillation (AF) and hypertension. Longitudinal data on left atrial (LA) remodeling during treatment are limited. We characterized serial changes in LA size and function during chronic ibrut...
Matea Kolacevic Zeljkovic, Sandra Bašić-Kinda, D. Čaržavec et al.
· Frontiers in Cardiovascular... · 0 citations